Bovine immune response to Shiga-toxigenic Escherichia coli O157:H7

Clinical and Vaccine Immunology

Volumn 13, Issue 12, 2006, Pages 1322-1327

  Hoffman, Mark A ^a,d   Menge, Christian ^b   Casey, Thomas A ^a   Laegreid, William ^c   Bosworth, Brad T ^a,e   Dean Nystrom, Evelyn A ^a,f  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c U S MEAT ANIMAL RESEARCH CENTER   (United States)

^d CERNER CORPORATION   (United States)

^e Novaitis Animal Health US Inc   (United States)

^f AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; COW; ESCHERICHIA COLI O157; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; CATTLE; CATTLE DISEASES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; SHIGA-LIKE TOXIN II;

EID: 33846121589     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00205-06     Document Type: Article

References (38)

1. Basu, I., W. A. Ferens, D. M. Stone, and C. J. Hovde. 2003. Antiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells. Infect. Immun. 71:327-334.
2. Besser, T. E., B. L. Richards, D. H. Rice, and D. D. Hancock. 2001. Escherichia coli O157:H7 infection of calves: infectious dose and direct contact transmission. Epidemiol. Infect. 127:555-560.
3. Besser, T. E., D. D. Hancock, L. C. Pritchett, E. M. McRae, D. H. Rice, and P. I. Tarr. 1997. Duration of detection of fecal excretion of Escherichia coli O157:H7 in cattle. J. Infect. Dis. 175:726-729.
4. Best, A., R. M. La Ragione, A. R. Sayers, and M. J. Woodward. 2005. Role for flagella but not intimin in the persistent infection of the gastrointestinal tissues of specific-pathogen-free chicks by Shiga toxin-negative Escherichia coli O157:H7. Infect. Immun. 73:1836-1846.
5. Christopher-Hennings, J., J. A. Willgohs, D. H. Francis, U. A. K. Raman, R. A. Moxley, and D. J. Hurley. 1993. Immunocompromise in gnotobiotic pigs induced by verotoxin-producing Escherichia coli. Infect. Immun. 61: 2304-2308.
6. Cobbold, R., and P. Desmarchelier. 2001. Characterisation and clonal relationships of Shiga-toxigenic Escherichia coli (STEC) isolated from Australian dairy cattle. Vet. Microbiol. 79:323-335.
7. Cornick, N. A., S. L. Booher, T. A. Casey, and H. W. Moon. 2000. Persistent colonization of sheep by Escherichia coli O157:H7 and other E. coli pathotypes. Appl. Environ. Microbiol. 66:4926-4934.
8. Cray, W. C., Jr., and H. W. Moon. 1995. Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl. Environ. Microbiol. 61: 1586-1590.
9. Dean-Nystrom, E. A., B. T. Bosworth, W. C. Cray, Jr., and H. W. Moon. 1997. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect. Immun. 65:1842-1848.
10. Dean-Nystrom, E. A., B. T. Bosworth, H. W. Moon, and A. D. O'Brien. 1998. Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect. Immun. 66:4560-4563.
11. Dziva, F., P. M. van Diemen, M. P. Stevens, A. J. Smith, and T. S. Wallis. 2004. Identification of Escherichia coli O157:H7 genes influencing colonization of the bovine gastrointestinal tract using signature-tagged mutagenesis. Microbiology 150:3631-3645.
12. Ferens, W. A., L. J. Grauke, and C. J. Hovde. 2004. Shiga toxin 1 targets bovine leukemia virus-expressing cells. Infect. Immun. 72:1837-1840.
13. Ferens, W. A., and C. J. Hovde. 2000. Antiviral activity of Shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation. Infect. Immun. 68:4462-4469.
14. Geue, L., M. Segura-Alvarez, F. J. Conraths, T. Kuczius, J. Bockemuhl, H. Karen, and P. Gallien. 2002. A long-term study on the prevalence of shiga toxin-producing Escherichia coli (STEC) on four German cattle farms. Epidemiol. Infect. 129:173-185.
15. Gordon, V. M., S. C. Whipp, H. W. Moon, A. D. O'Brien, and J. E. Samuel. 1992. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine. Infect. Immun. 60:485-490.
16. Griffin, P. M. 1998. Epidemiology of Shiga toxin-producing Escherichia coli infections in humans in the United States, pp. 15-22. In James B. Kaper and Alison D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D. C.
17. Johnson, R. P., W. C. Cray, Jr., and S. T. Johnson. 1996. Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7. Infect. Immun. 64:1879-1883.
18. Jordan, D. M., S. L. Booher, and H. W. Moon. 2005. Escherichia coli O157:H7 does not require intimin to persist in pigs. Infect. Immun. 73:1865-1867.
19. Karpman, D., H. Connell, M. Svensson, F. Scheutz, P. Aim, and C. Svandborg. 1997. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J. Infect. Dis. 175:611-620.
20. Laegreid, W., M. Hoffman, J. Keen, R. Elder, and J. Kwang. 1998. Development of a blocking enzyme-linked immunosorbent assay for detection of serum antibodies to O157 antigen of Escherichia coli. Clin. Diagn. Lab. Immunol. 5:242-246.
21. Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. V. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
22. Menge, C., M. Blessenohl, T. Eisenberg, I. Stamm, and G. Baljer. 2004. Bovine ileal intraepithelial lymphocytes represent target cells for Shiga toxin 1 from Escherichia coli. Infect. Immun. 72:1896-1905.
23. Menge, C., I. Stamm, M. Blessenohl, L. H. Wieler, and G. Baljer. 2003. Verotoxin 1 from Escherichia coli affects Gb3/CD77+ bovine lymphocytes independent of interleukin-2, tumor necrosis factor-alpha, and interferon-alpha. Exp. Biol. Med. (Maywood) 228:377-386.
24. Menge, C., I. Stamm, P. M. Van Diemen, P. Sopp, G. Baljer, T. S. Wallis, and M. P. Stevens. 2004. Phenotypic and functional characterization of intraepithelial lymphocytes in a bovine ligated intestinal loop model of enterohaemorrhagic Escherichia coli infection. J. Med. Microbiol. 53:573-579.
25. Menge, C., L. H. Wieler, T. Schlapp, and G. Baljer. 1999. Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro. Infect. Immun. 67:2209-2217.
26. Moxley, R. A. 2004. Escherichia coli O157:H7: an update on intestinal colonization and virulence mechanisms. Anim. Health Res. Rev. 5:15-33.
27. O'Brien, A. D., and R. K. Holmes. 1987. Shiga and Shiga-like toxins. Microbiol. Rev. 51:206-220.
28. Pirro, F., L. H. Wieler, K. Failing, R. Bauerfeind, and G. Baljer. 1995. Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera of cattle. Vet. Microbiol. 43:131-141.
29. Proulx, F., E. G. Seidman, and D. Karpman. 2001. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr. Res. 50:163-171.
30. Rangel, J., P. Sparling, C. Crowe, P. Griffin, and D. L. Swerdlow. 2005. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg. Infect. Dis. 11:603-609.
31. Stamm, I., M. Wuhrer, R. Geyer, G. Baljer, and C. Menge. 2002. Bovine lymphocytes express functional receptors for Escherichia coli Shiga toxin 1. Microb. Pathog. 33:251-264.
32. Stevens, M. P., P. M. van Diemen, G. Frankel, A. D. Phillips, and T. S. Wallis. 2002. Efa1 influences colonization of the bovine intestine by shiga toxin-producing Escherichia coli serotypes O5 and O111. Infect. Immun. 70:5158-5166.
33. Stoffregen, W. C., J. F. L. Pohlenz, and E. A. Dean-Nystrom. 2004. Escherichia coli O157:H7 in the gallbladders of experimentally infected calves. J. Vet. Diagn. Investig. 16:79-83.
34. Sugatani, J., T. Igarashi, M. Shimura, T. Yamanaka, T. Takeda, and M. Miwa. 2000. Disorders in the immune responses of T- and B-cells in mice administered intravenous verotorin 2. Life Sci. 67:1059-1072.
35. Tarr, P. I., and M. A. Neill. 1996. Perspective: the problem of non-O157:H7 Shiga toxin (verocytotoxin)-producing Escherichia coli. J. Infect. Dis. 174: 1136-1139.
36. Tarr, P. I., M. A. Neill, C. R. Clausen, J. W. Newland, R. J. Neill, and S. L. Moseley. 1989. Genotypic variation in pathogenic Escherichia coli O157: H7 isolated from patients in Washington, 1984-1987. J. Infect. Dis. 159: 344-347.
37. Tesh, V. L., and A. D. O'Brien. 1991. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol. Microbiol. 5:1817-1822.
38. Westerman, R. B., Y. He, J. E. Keen, E. T. Littledike, and J. Kwang. 1997. Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157:H7. J. Clin. Microbiol. 35:679-684.